PCV29 COST-EFFECTIVENESS OF REDUCTION IN CARDIOVASCULAR OUTCOMES WITH ATORVASTATIN IN PATIENTS WITH NORMAL TO MILDLY ELEVATED CHOLESTEROL LEVELS.TREATED FOR HYPERTENSION- THE ASCOT-LLA STUDY
Nov 1, 2004, 00:00
10.1016/S1098-3015(10)65811-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)65811-1/fulltext
Title :
PCV29 COST-EFFECTIVENESS OF REDUCTION IN CARDIOVASCULAR OUTCOMES WITH ATORVASTATIN IN PATIENTS WITH NORMAL TO MILDLY ELEVATED CHOLESTEROL LEVELS.TREATED FOR HYPERTENSION- THE ASCOT-LLA STUDY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65811-1&doi=10.1016/S1098-3015(10)65811-1
First page :
Section Title :
Open access? :
No
Section Order :
178